Mishima Gerhart
General Counsel at PLIANT THERAPEUTICS, INC.
Profile
Mishima Gerhart is currently the Chief Regulatory Officer at Pliant Therapeutics, Inc. Prior to this, Mishima held positions as the Head-Regulatory Affairs at Genzyme Corp.
from 2014 to 2016, and as the Head-Global Regulatory Affairs at Sanofi from 2016 to 2020.
Mishima also served as the Chief Regulatory Officer & Head-Quality at Taysha Gene Therapies, Inc. Mishima's education includes an undergraduate degree from Kutztown University of Pennsylvania and a graduate degree from Temple University (Pennsylvania).
Mishima Gerhart active positions
| Companies | Position | Start |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | General Counsel | 16/10/2023 |
Former positions of Mishima Gerhart
| Companies | Position | End |
|---|---|---|
| SANOFI | General Counsel | 01/06/2020 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | 01/01/2016 |
| TAYSHA GENE THERAPIES, INC. | General Counsel | - |
Training of Mishima Gerhart
| Kutztown University of Pennsylvania | Undergraduate Degree |
| Temple University (Pennsylvania) | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| TAYSHA GENE THERAPIES, INC. | Health Technology |
| SANOFI | Health Technology |
| PLIANT THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Mishima Gerhart
